Crossmark

A programmable platelet theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis

Crossref DOI link: https://doi.org/10.1038/s41467-025-61789-9

Published Online: 2025-07-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yi

Li, Xueping

Chen, Ting

Li, Jian

Qi, Ji https://orcid.org/0000-0001-7597-9725
Li, Wen https://orcid.org/0000-0001-6783-1464
License Information

Text and Data Mining valid from 2025-07-11

Version of Record valid from 2025-07-11
More Information

Article History

Received: 10 December 2024

Accepted: 1 July 2025

First Online: 11 July 2025

Competing interests

: The authors declare no competing interests.